MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,960 Approvals
Showing 361 to 380 of 1,960 approvalsPage 19 of 98

Kerendia

Authorisation: Feb 16, 2022
BAYER AG

Tepmetko

Authorisation: Feb 16, 2022
Merck Europe BV

Okedi

Authorisation: Feb 14, 2022
LABORATORIOS FARMACEUTICOS ROVI SA

Ngenla

Authorisation: Feb 14, 2022
Pfizer Europe MA EEIG

Saphnelo

Authorisation: Feb 14, 2022
ASTRAZENECA AB

Oxbryta

Authorisation: Feb 14, 2022
Pfizer Europe MA EEIG

Paxlovid

Authorisation: Jan 28, 2022
Pfizer Europe MA EEIG

Paxlovid

Authorisation: Jan 28, 2022
Pfizer Europe MA EEIG

Vyepti

Authorisation: Jan 24, 2022
H. Lundbeck A/S

Voraxaze

Authorisation: Jan 11, 2022
SERB SAS

Lumykras

Authorisation: Jan 6, 2022
Amgen Europe BV

Wegovy

Authorisation: Jan 6, 2022
Novo Nordisk A/S

Tecovirimat SIGA

Authorisation: Jan 6, 2022
siga technologies netherlands b.v.

Riltrava Aerosphere

Authorisation: Jan 6, 2022
ASTRAZENECA AB

Riltrava Aerosphere

Authorisation: Jan 6, 2022
ASTRAZENECA AB

Nuvaxovid

Authorisation: Dec 20, 2021
NOVAVAX CZ a.s.

Nuvaxovid

Authorisation: Dec 20, 2021
NOVAVAX CZ a.s.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.